UK MHRA Approves Antibody Therapy of Regeneron for Treating Covid-19 Patients

The company ‘Regeneron Pharmaceuticals Inc., announced, the Medicines and Healthcare Products Regulatory Agency (MHRA) of United Kingdom has given the approval to the Conditional Marketing Authorization (CMA) for the imdevimab and casirivimab antibody cocktail, that has been known as REGEN-COV in the United States and Ronapreve in the United Kingdom and several other countries for […]

Continue Reading